Baidu
map

Cell Metabol:跑步帮小鼠抗癌 人也可以吗?

2016-02-19 佚名 生物谷

锻炼的好处之一就是,相比于不爱活动的小鼠而言,每天利用空闲时间跑转轮的小鼠机体肿瘤的尺寸会明显减少,近日刊登在Cell Metabolism上的一项研究报告中,来自哥本哈根大学的研究人员通过研究发现,高强度锻炼引发的肾上腺素的激增有助于将杀灭癌细胞的免疫NK细胞移动至植入小鼠机体的肺部、肝脏或皮肤肿瘤患处部位。研究者Pernille Hojman说道,我们都知道自然杀伤细胞(NK细胞)可以控制并且

锻炼的好处之一就是,相比于不爱活动的小鼠而言,每天利用空闲时间跑转轮的小鼠机体肿瘤的尺寸会明显减少,近日刊登在Cell Metabolism上的一项研究报告中,来自哥本哈根大学的研究人员通过研究发现,高强度锻炼引发的肾上腺素的激增有助于将杀灭癌细胞的免疫NK细胞移动至植入小鼠机体的肺部、肝脏或皮肤肿瘤患处部位。

研究者Pernille Hojman说道,我们都知道自然杀伤细胞(NK细胞)可以控制并且调节肿瘤的尺寸,但并没有人清楚锻炼如何调节该过程;在本文研究中,研究者就尝试向小鼠机体注射肾上腺素来模拟锻炼期间肾上腺素水平的增加,当注射肾上腺素后研究者们发现NK细胞就会开始运动进入血液,如果存在肿瘤这些NK细胞就会找到肿瘤并且对其进行作用。

随后研究者利用剔除NK细胞的小鼠进行研究发现,肿瘤位点NK细胞数量的增加会直接降低肿瘤发展的尺寸,甚至是经过锻炼并且给予一系列其它的免疫细胞,如果没有NK细胞这些小鼠依然会经历正常速率的癌症发展,阻断肾上腺素的功能同时还可以钝化小鼠转圈带来的抗癌效益。

名为IL-6的免疫信号分子是NK细胞进行的肾上腺素依赖的动员和肿瘤渗透之间的关联所在,在运动期间肌肉组织会释放IL-6,但研究者发现肾上腺素会以特殊的方式“欢迎”IL-6敏感性的NK细胞,同时IL-6分子还可以帮助指导免疫细胞进入到肿瘤位置。研究者指出,锻炼诱导的IL-6似乎在将NK细胞召唤到肿瘤中扮演着特殊的角色,同时也可以有效激活NK细胞。

研究人员希望病人可以寻找其它廉价的方式来控制癌症的发生,多锻炼身体或可有效抑制肿瘤转移发展,后期研究者想进一步开发多种联合性的抗癌疗法,当前研究数据显示进行合适的高强度锻炼似乎是有益的,其可以刺激肾上腺素的分泌以及增强NK细胞的功能。

原始出处:


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1895883, encodeId=4ce8189588328, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Sep 07 05:14:00 CST 2016, time=2016-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1869303, encodeId=b4b5186930365, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Mon Jan 23 05:14:00 CST 2017, time=2017-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1959559, encodeId=05e71959559f2, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Mon Jan 16 09:14:00 CST 2017, time=2017-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1887508, encodeId=be09188e50837, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Tue May 10 02:14:00 CST 2016, time=2016-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493891, encodeId=98e6149389136, content=<a href='/topic/show?id=949e9304149' target=_blank style='color:#2F92EE;'>#跑步#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93041, encryptionId=949e9304149, topicName=跑步)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37959125862, createdName=yahu, createdTime=Sun Feb 21 01:14:00 CST 2016, time=2016-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1597946, encodeId=4ae6159e94649, content=<a href='/topic/show?id=6c6f1e62c5' target=_blank style='color:#2F92EE;'>#ABO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1762, encryptionId=6c6f1e62c5, topicName=ABO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6c918580135, createdName=闆锋旦, createdTime=Sun Feb 21 01:14:00 CST 2016, time=2016-02-21, status=1, ipAttribution=)]
    2016-09-07 一闲
  2. [GetPortalCommentsPageByObjectIdResponse(id=1895883, encodeId=4ce8189588328, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Sep 07 05:14:00 CST 2016, time=2016-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1869303, encodeId=b4b5186930365, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Mon Jan 23 05:14:00 CST 2017, time=2017-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1959559, encodeId=05e71959559f2, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Mon Jan 16 09:14:00 CST 2017, time=2017-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1887508, encodeId=be09188e50837, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Tue May 10 02:14:00 CST 2016, time=2016-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493891, encodeId=98e6149389136, content=<a href='/topic/show?id=949e9304149' target=_blank style='color:#2F92EE;'>#跑步#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93041, encryptionId=949e9304149, topicName=跑步)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37959125862, createdName=yahu, createdTime=Sun Feb 21 01:14:00 CST 2016, time=2016-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1597946, encodeId=4ae6159e94649, content=<a href='/topic/show?id=6c6f1e62c5' target=_blank style='color:#2F92EE;'>#ABO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1762, encryptionId=6c6f1e62c5, topicName=ABO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6c918580135, createdName=闆锋旦, createdTime=Sun Feb 21 01:14:00 CST 2016, time=2016-02-21, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1895883, encodeId=4ce8189588328, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Sep 07 05:14:00 CST 2016, time=2016-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1869303, encodeId=b4b5186930365, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Mon Jan 23 05:14:00 CST 2017, time=2017-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1959559, encodeId=05e71959559f2, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Mon Jan 16 09:14:00 CST 2017, time=2017-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1887508, encodeId=be09188e50837, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Tue May 10 02:14:00 CST 2016, time=2016-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493891, encodeId=98e6149389136, content=<a href='/topic/show?id=949e9304149' target=_blank style='color:#2F92EE;'>#跑步#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93041, encryptionId=949e9304149, topicName=跑步)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37959125862, createdName=yahu, createdTime=Sun Feb 21 01:14:00 CST 2016, time=2016-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1597946, encodeId=4ae6159e94649, content=<a href='/topic/show?id=6c6f1e62c5' target=_blank style='color:#2F92EE;'>#ABO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1762, encryptionId=6c6f1e62c5, topicName=ABO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6c918580135, createdName=闆锋旦, createdTime=Sun Feb 21 01:14:00 CST 2016, time=2016-02-21, status=1, ipAttribution=)]
    2017-01-16 维他命
  4. [GetPortalCommentsPageByObjectIdResponse(id=1895883, encodeId=4ce8189588328, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Sep 07 05:14:00 CST 2016, time=2016-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1869303, encodeId=b4b5186930365, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Mon Jan 23 05:14:00 CST 2017, time=2017-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1959559, encodeId=05e71959559f2, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Mon Jan 16 09:14:00 CST 2017, time=2017-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1887508, encodeId=be09188e50837, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Tue May 10 02:14:00 CST 2016, time=2016-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493891, encodeId=98e6149389136, content=<a href='/topic/show?id=949e9304149' target=_blank style='color:#2F92EE;'>#跑步#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93041, encryptionId=949e9304149, topicName=跑步)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37959125862, createdName=yahu, createdTime=Sun Feb 21 01:14:00 CST 2016, time=2016-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1597946, encodeId=4ae6159e94649, content=<a href='/topic/show?id=6c6f1e62c5' target=_blank style='color:#2F92EE;'>#ABO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1762, encryptionId=6c6f1e62c5, topicName=ABO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6c918580135, createdName=闆锋旦, createdTime=Sun Feb 21 01:14:00 CST 2016, time=2016-02-21, status=1, ipAttribution=)]
    2016-05-10 guojianrong
  5. [GetPortalCommentsPageByObjectIdResponse(id=1895883, encodeId=4ce8189588328, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Sep 07 05:14:00 CST 2016, time=2016-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1869303, encodeId=b4b5186930365, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Mon Jan 23 05:14:00 CST 2017, time=2017-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1959559, encodeId=05e71959559f2, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Mon Jan 16 09:14:00 CST 2017, time=2017-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1887508, encodeId=be09188e50837, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Tue May 10 02:14:00 CST 2016, time=2016-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493891, encodeId=98e6149389136, content=<a href='/topic/show?id=949e9304149' target=_blank style='color:#2F92EE;'>#跑步#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93041, encryptionId=949e9304149, topicName=跑步)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37959125862, createdName=yahu, createdTime=Sun Feb 21 01:14:00 CST 2016, time=2016-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1597946, encodeId=4ae6159e94649, content=<a href='/topic/show?id=6c6f1e62c5' target=_blank style='color:#2F92EE;'>#ABO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1762, encryptionId=6c6f1e62c5, topicName=ABO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6c918580135, createdName=闆锋旦, createdTime=Sun Feb 21 01:14:00 CST 2016, time=2016-02-21, status=1, ipAttribution=)]
    2016-02-21 yahu
  6. [GetPortalCommentsPageByObjectIdResponse(id=1895883, encodeId=4ce8189588328, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Sep 07 05:14:00 CST 2016, time=2016-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1869303, encodeId=b4b5186930365, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Mon Jan 23 05:14:00 CST 2017, time=2017-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1959559, encodeId=05e71959559f2, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Mon Jan 16 09:14:00 CST 2017, time=2017-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1887508, encodeId=be09188e50837, content=<a href='/topic/show?id=d56611584ec' target=_blank style='color:#2F92EE;'>#Meta#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11584, encryptionId=d56611584ec, topicName=Meta)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8f4110, createdName=guojianrong, createdTime=Tue May 10 02:14:00 CST 2016, time=2016-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493891, encodeId=98e6149389136, content=<a href='/topic/show?id=949e9304149' target=_blank style='color:#2F92EE;'>#跑步#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93041, encryptionId=949e9304149, topicName=跑步)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37959125862, createdName=yahu, createdTime=Sun Feb 21 01:14:00 CST 2016, time=2016-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1597946, encodeId=4ae6159e94649, content=<a href='/topic/show?id=6c6f1e62c5' target=_blank style='color:#2F92EE;'>#ABO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1762, encryptionId=6c6f1e62c5, topicName=ABO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6c918580135, createdName=闆锋旦, createdTime=Sun Feb 21 01:14:00 CST 2016, time=2016-02-21, status=1, ipAttribution=)]
    2016-02-21 闆锋旦

相关资讯

Br J Surg:左肝切除术后结局分析

左肝三叶切除术(LHT)是十分具有挑战的解剖性肝切除术,全球范围内该手术的经验有限,术后并发症发生率尤其高。研究者对1993-2013年间进行了LHT的113名患者进行了一项队列研究,分析这些患者的预后,以及识别与术后长期和短期结局相关的因素。纳入研究的113名患者中有57名为结直肠癌肝转移,22名为肝门部胆管癌,12名为肝内胆管癌,11名为肝细胞性肝癌,还有11名患者有其他各种手术指征。整体上这

英国癌症患病率20年间上升12%

英国癌症研究会17日发布的数据显示,英国癌症患病率近年来呈上升趋势,自上世纪90年代中期以来,这一比例已上升了12%。 据该机构提供的数据,2011年到2013年间,每10万当地居民中就有603人被诊断患有癌症;而1993年到1995年间,每10万当地居民中有540人患癌。从性别看,每年患癌的男性数量要高于女性。 尽管癌症患病率有所上升,但当地的癌症生存率也在不断提高中。数据显示,过去40年里

PNAS:癌细胞转移战略----成群结队,提高成功率

图片来源:medicalxpress.com 最近,一项刊登于国际杂志Proceedings of the National Academy of Sciences上的研究论文中,来自约翰霍普金斯大学的研究人员通过对小鼠进行研究发现,癌细胞很少凭自己形成转移性肿瘤,而是喜欢在机体个组织间“巡游”最终成功地完成转移;同时研究者还发现,移动中的细胞同原发性肿瘤部位中进行繁殖的细胞并不相同,而

Lancet子刊:不是伪科学!身高确实影响糖尿病及癌症风险

一项刊登于国际杂志The Lancet Diabetes & Endocrinology上的研究论文中,来自德国糖尿病研究中心等机构的研究人员通过研究描述了全世界个体升高增加和患慢性非传染性疾病之间的关联;研究人员发现,高个儿人患心血管疾病和2型糖尿病的风险较低,但患癌风险却很高,同时研究者还讨论了饮食因素和其它机制试图来解释上述关联性发生的原因。身高通过遗传来决定,但近些年来全球各地儿童

JCO:癌症不同,心血管疾病风险不同

 据估计,美国现如今有一千四百万癌症幸存者,到2024年这一数字将达到一千九百万。在这些癌症幸存者中,三分之二已经在癌症诊断后存活了超过五年,每五个幸存者中有两个被认为可以存活达到十年。这也直接导致了癌症患病人群的老龄化。目前,心血管疾病已经成为了主要的导致发病率和死亡率的原因。对于儿童以及年龄在四十岁以下的年轻人被诊断为癌症的患者,心血管疾病,包括缺血性心脏病、卒中和心衰其与癌症治疗相

A型危险,O型就安全,血型与癌症真有关系么?

ABO血型是根据红细胞膜上是否存在抗原A与抗原B分为4型:仅有A抗原为A型,仅有B抗原为B型,同时存在A和B抗原则为AB型,这两种抗原均无为O型。国人A型、B型及O型血各占约30%,AB型仅占10%左右。父母的血型决定了宝宝的血型,“血型与癌症的关系说”在2009年前国外有一些报道,当时比较热,这几年专业领域没人再提这事了。 关键词一:肿瘤专业领域不认可“血型是癌症的危险因素”

Baidu
map
Baidu
map
Baidu
map